| __timestamp | Amphastar Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 85181000 |
| Thursday, January 1, 2015 | 37065000 | 135253000 |
| Friday, January 1, 2016 | 41199000 | 162297000 |
| Sunday, January 1, 2017 | 43415000 | 198442000 |
| Monday, January 1, 2018 | 57564000 | 226616000 |
| Tuesday, January 1, 2019 | 68853000 | 299726000 |
| Wednesday, January 1, 2020 | 67229000 | 335375000 |
| Friday, January 1, 2021 | 60932000 | 505748000 |
| Saturday, January 1, 2022 | 74771000 | 590453000 |
| Sunday, January 1, 2023 | 73741000 | 849658000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc. have shown distinct approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Jazz Pharmaceuticals consistently outspent Amphastar, with R&D expenses growing from approximately $85 million to a staggering $850 million, marking a tenfold increase. In contrast, Amphastar's R&D spending rose from about $28 million to $74 million, reflecting a more modest growth.
Jazz Pharmaceuticals' commitment to innovation is evident, with its R&D spending increasing by over 900% in this period, compared to Amphastar's 160% increase. This significant investment underscores Jazz's strategy to prioritize innovation as a driver for growth and competitiveness. As the pharmaceutical landscape evolves, these spending patterns highlight the varying strategies companies adopt to foster innovation and maintain market relevance.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Incyte Corporation vs Jazz Pharmaceuticals plc
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds